Intertek To Expand And Relocate Its Bioanalytical LC-MS Facility
News Mar 18, 2015
Intertek has announced the expansion and relocation of its bioanalytical liquid chromatography– mass spectrometry (LC-MS) facility in El Dorado Hills, California to Intertek’s existing center of excellence facility in San Diego.
The relocation to the San Diego facility will be completed by June 2015. The increased laboratory capacity of the San Diego facility, which spans 46,000 square feet of laboratories, offices and sample storage, will benefit customers involved in preclinical and clinical small molecule drug development. This will be coupled with investment in new state-of-the-art mass spectrometers which will be operational at the new San Diego LC-MS facility prior to relocation and so avoid service delivery interruption.
Existing large molecule bioanalysis services from the immunochemistry laboratory in San Diego will be strengthened by expanded capability for bioanalytical LC-MS evaluation of biologic drugs such as proteins, antibody therapeutics or biosimilars as a result of the relocation and investment.
Chetan Parmar, Senior Vice President of Intertek Life Sciences, said “Expanding and consolidating our bioanalytical capacity will strengthen our capability to address the challenges our clients encounter during increasingly complex drug development programs and provide them with the right data for informed decision-making".
Intertek has been providing Good Laboratory Practice (GLP) compliant bioanalytical services to global pharmaceutical clients supporting their preclinical and clinical studies for over 20 years and the combined bioanalytical LC-MS/immunochemistry facility will be a key part of Intertek’s network of state-of-the art GLP-compliant laboratories.
After Cooking, Biofortified Corn and Eggs Retain Nutrient Needed to Prevent BlindnessNews
Researchers showed that foods fortified with carotenoids retained their beneficial properties following most types of household cooking methods.READ MORE
Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's DiseaseNews
Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.READ MORE
New Player in Alzheimer's Disease Pathogenesis IdentifiedNews
Using proteomics, microscopic analysis, and functional assays, scientists have shown that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check.READ MORE